Study Highlights Genital Numbness in Post-SSRI Patients
A recent study published in Social Psychiatry and Psychiatric Epidemiology has revealed a significant association between antidepressant use and persistent genital numbness, known as Persistent Post-Treatment Genital Hypoesthesia (PPTGH). The study surveyed 2,179 young participants, with a notable 13.2% of those who had used antidepressants reporting continued genital numbness after discontinuation, compared to only 0.9% among those using other psychiatric medications.
The findings highlight the need for increased transparency in prescribing practices and improved informed consent processes, especially for young patients. This research stresses the importance of recognizing and managing the long-term sexual side effects associated with antidepressants.
For more details, visit the full study here.
Learn more about PFS & PSSD
What is Post-Finasteride Syndrome?
PFS (Post-Finasteride Syndrome) is a complex and life-altering condition caused by the drug Finasteride (also marketed as Propecia) and other 5ar inhibitors. It affects physical, mental, and sexual health, leaving patients to suffer without adequate support, recognition or treatment.
What is Post-SSRI Sexual Dysfunction?
PSSD (Post-SSRI Sexual Dysfunction) is a serious and debilitating condition associated with the use of selective serotonin reuptake inhibitors (SSRIs) and similar drugs. It affects mental, physical, and sexual well-being, leaving many patients to suffer without sufficient support, recognition, or effective treatment.
